Found: 49
Select item for more details and to access through your institution.
CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0425-4
- By:
- Publication type:
- Article
PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0317-7
- By:
- Publication type:
- Article
SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0267-5
- By:
- Publication type:
- Article
PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0270-x
- By:
- Publication type:
- Article
Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA.
- Published in:
- Nucleic Acids Research, 2007, v. 35, n. 1, p. e4, doi. 10.1093/nar/gkl955
- By:
- Publication type:
- Article
Corrigendum: Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
- Published in:
- Nature Genetics, 2014, v. 46, n. 7, p. 759, doi. 10.1038/ng0714-759b
- By:
- Publication type:
- Article
Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.
- Published in:
- Nature Genetics, 2014, v. 46, n. 6, p. 613, doi. 10.1038/ng.2956
- By:
- Publication type:
- Article
FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen.
- Published in:
- HNO, 2021, v. 69, n. 3, p. 172, doi. 10.1007/s00106-020-00893-2
- By:
- Publication type:
- Article
Current status and future perspectives of circulating cell-free DNA methylation in clinical diagnostics.
- Published in:
- Journal of Laboratory Medicine / Laboratoriums Medizin, 2016, v. 40, n. 5, p. 335, doi. 10.1515/labmed-2016-0039
- By:
- Publication type:
- Article
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01525-6
- By:
- Publication type:
- Article
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01270-2
- By:
- Publication type:
- Article
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors
- Published in:
- Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01212-4
- By:
- Publication type:
- Article
Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118195
- By:
- Publication type:
- Article
Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0093933
- By:
- Publication type:
- Article
Diagnostic and Prognostic Value of <i>SHOX2</i> and <i>SEPT9</i> DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0084225
- By:
- Publication type:
- Article
Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077771
- By:
- Publication type:
- Article
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab).
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1781, doi. 10.1007/s00262-020-02777-4
- By:
- Publication type:
- Article
ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00508-2
- By:
- Publication type:
- Article
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 482, doi. 10.3390/cancers16030482
- By:
- Publication type:
- Article
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 111, n. 3, p. 429, doi. 10.1007/s10549-007-9800-8
- By:
- Publication type:
- Article
Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF.
- Published in:
- Nucleic Acids Research, 2004, v. 32, n. 21, p. e167, doi. 10.1093/nar/gnh165
- By:
- Publication type:
- Article
Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
- Published in:
- Clinical Chemistry, 2024, v. 70, n. 3, p. 516, doi. 10.1093/clinchem/hvad230
- By:
- Publication type:
- Article
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 9, p. 1050, doi. 10.1093/clinchem/hvad084
- By:
- Publication type:
- Article
Cell-Free SHOX2 DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort Study.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 4, p. 559, doi. 10.1373/clinchem.2018.297549
- By:
- Publication type:
- Article
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 7, p. 1288, doi. 10.1373/clinchem.2016.270207
- By:
- Publication type:
- Article
Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Extensive transcriptional complexity during hypoxia-regulated expression of the myoglobin gene in cancer.
- Published in:
- Human Molecular Genetics, 2014, v. 23, n. 2, p. 479, doi. 10.1093/hmg/ddt438
- By:
- Publication type:
- Article
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-00883-9
- By:
- Publication type:
- Article
H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-0818-7
- By:
- Publication type:
- Article
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0752-8
- By:
- Publication type:
- Article
DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0165769
- By:
- Publication type:
- Article
Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2015, v. 466, n. 2, p. 133, doi. 10.1007/s00428-014-1689-0
- By:
- Publication type:
- Article
Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2014, v. 465, n. 4, p. 419, doi. 10.1007/s00428-014-1646-y
- By:
- Publication type:
- Article
Diagnosis of Li‐Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis.
- Published in:
- Human Mutation, 2018, v. 39, n. 12, p. 2040, doi. 10.1002/humu.23653
- By:
- Publication type:
- Article
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0192-7
- By:
- Publication type:
- Article
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 2, p. 309, doi. 10.1111/pcmr.13151
- By:
- Publication type:
- Article
Identification of cytokeratin24 as a tumor suppressor for the management of head and neck cancer.
- Published in:
- Biological Chemistry, 2022, v. 403, n. 8/9, p. 869, doi. 10.1515/hsz-2021-0287
- By:
- Publication type:
- Article
Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 4, p. 565, doi. 10.1093/jnci/djab231
- By:
- Publication type:
- Article
Regulation of Endothelial Nitric Oxide Synthase in the Reticular Lamina of the Organ of Corti by a Nitric Oxide Donor.
- Published in:
- Journal of Histochemistry & Cytochemistry, 2021, v. 69, n. 11, p. 731, doi. 10.1369/00221554211054642
- By:
- Publication type:
- Article
Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.
- Published in:
- Clinical Endocrinology, 2015, v. 83, n. 6, p. 779, doi. 10.1111/cen.12873
- By:
- Publication type:
- Article
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192742
- By:
- Publication type:
- Article
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0179412
- By:
- Publication type:
- Article
Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 102, doi. 10.1186/1471-2407-11-102
- By:
- Publication type:
- Article
SHOX2 DNA Methylation is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates.
- Published in:
- BMC Cancer, 2010, v. 10, p. 600, doi. 10.1186/1471-2407-10-600
- By:
- Publication type:
- Article
CDO1 Promoter Methylation is a Biomarker forOutcome Prediction of Anthracycline Treated,Estrogen Receptor-Positive, Lymph Node-PositiveBreast Cancer Patients.
- Published in:
- BMC Cancer, 2010, v. 10, p. 247, doi. 10.1186/1471-2407-10-247
- By:
- Publication type:
- Article